ConvaTec Group (OTCMKTS:CNVVY – Get Free Report) is expected to issue its resultson Tuesday, August 4th. Analysts expect the company to post earnings of $0.3290 per share and revenue of $1.2257 billion for the quarter.
ConvaTec Group Trading Up 1.2%
Shares of CNVVY stock traded up $0.14 during trading hours on Tuesday, reaching $12.00. The company’s stock had a trading volume of 2,212 shares, compared to its average volume of 60,995. The firm’s 50 day simple moving average is $11.17 and its 200-day simple moving average is $11.94. ConvaTec Group has a fifty-two week low of $10.45 and a fifty-two week high of $14.09.
About ConvaTec Group
ConvaTec Group is a global medical products and technologies company focused on developing therapies and technologies for the management of chronic health conditions. The company’s portfolio spans four core business areas—Advanced Wound Care, Ostomy Care, Continence & Critical Care, and Infusion Devices—which are designed to improve patient outcomes and enhance quality of life for people living with long-term health challenges. ConvaTec’s product range includes proprietary wound dressings, ostomy and continence management systems, and safety-engineered infusion sets.
Headquartered in Reading, United Kingdom, ConvaTec serves customers in over 100 countries through a network of manufacturing, distribution, and customer support operations.
Featured Articles
- Five stocks we like better than ConvaTec Group
- 5 Space Stocks Face a Brutal Correction: Which Ones Are Still Buys?
- Whirlpool’s Report May Show How Frozen the Housing Market Really Is
- 3 Stocks Standing Out and 2 Losing Momentum as the Tech Rally Cracks
- 5 AI Stocks Are Pulling Back—Which Growth Catalysts Still Look Strongest?
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.
